Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/18/2024
Novo Nordisk Launches Weight Loss Drug Wegovy in China
11/13/2024
Shanghai Pharma Considers API Partnerships with Indian Drugmakers amid...
11/12/2024
Shanghai Pharma Eyes Stronger India Partnership for Global Growth
11/6/2024
Novo Nordisk Reports Strong Growth in China for 3Qs of 2024, Driven by...
10/30/2024
Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong
10/25/2024
China Succeeds in Reducing Premature Death from Chronic Diseases
10/21/2024
China Releases First National Guidelines for Obesity Diagnosis and Tre...
10/21/2024
China Sees Drop in Deaths from Chronic Diseases as Efforts Intensify A...
10/17/2024
Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...
10/15/2024
BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
10/15/2024
Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
10/1/2024
Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...
9/9/2024
NHC Issues the List of Pediatric Drugs Encouraged for R&D and Registra...
8/27/2024
BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
8/26/2024
Recent Study Reveals Alarming Rise in Obesity-Related Cancers in China
8/1/2024
NMPA Accepts NDA for Innovent's T2D Drug Mazdutide
7/22/2024
Gan & Lee Unveils Promising Mid-Stage Data for Homegrown Obesity Drug
7/19/2024
Eli Lilly Wins Label Expansion for Tirzepatide in China
7/19/2024
Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
7/18/2024
India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
7/10/2024
China Initiates New Awareness Campaign to Address Rising Obesity Rates
7/2/2024
What is the Current Landscape of Obesity Drug Development in China? (L...
6/27/2024
Novo Nordisk to Limit Wegovy Sales in China amid Supply Shortage
6/25/2024
Novo Nordisk's Wegovy Approved in China for Weight Loss
6/20/2024
Fosun to Reduce Its Stake in India's Gland Pharma
6/20/2024
Biocon Eyes China for Generic Diabetes and Weight-Loss Drug Trials
6/20/2024
Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
6/14/2024
Livzon Seeks Approval for Generic Version of Novo Nordisk's Ozempic
6/7/2024
Novo Nordisk Faces Stiff Generic Competition in China’s Weight-Loss D...
6/7/2024
CDE Solicits Comments on the Guidelines for Pediatric Clinical Trial D...
Page:
2
/
42
Total number of articles:
1247
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit